Two major metabolites of PYC, namely -(3,4-dihydroxyphenyl)--valerolactone (M1) and -(3-methoxy-4-hydroxyphenyl)--valerolactone, strongly inhibit matrix metalloproteinases (MMP-1, MMP-2, and MMP-9) activity, thereby inhibiting oxidative stress (Grimm et al., 2004)
Some studies and protocols have explored higher daily intakes, depending on the application and desired benefits
Rare risks include copper sensitivity or toxicity with prolonged use which is why we monitor copper levels with periodic blood tests
Treatment of Psoriasis In the 1980s, psoriasis was viewed as a keratinocyte-driven disease and the treatment employed was to inhibit proliferation of epithelial tissue using methotrexate, phototherapy, and retinoids
Although compared to SERT, the administration of SILY to DEX-treated mice was associated within reversal of memory deficits suggesting that as a sole or replacement therapy it could provide some benefits, large clinical studies are required to confirm these in humans
10.3390/ijms22010193 [DOI] [PMC free article] [PubMed] [Google Scholar] 60.Dassanayake TL, Kahathuduwa CN, Weerasinghe VS